Journal of microencapsulation

A tiny capsule method for delivering semaglutide through the nose

Updated

Abstract

Over 90% of semaglutide was retained after three months of storage at 4°C.

  • Nasal delivery of semaglutide could improve ease of use and patient compliance compared to injections.
  • Encapsulation efficiencies exceeded 95% at a semaglutide concentration of 0.5 mg/mL.
  • Formulations fully dissolved in nasal mucus within two hours, and over 30% absorption occurred in the first 20 minutes.
  • No adverse effects were observed in toxicological testing on nasal cell lines.
  • Higher trehalose content was associated with enhanced transport across nasal cells, achieving complete transport within two hours.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free